Objective-We previously established that neutrophil-derived dipeptidyl peptidase I (DPPI) is essential for experimental abdominal aortic aneurysm (AAA) development. Because DPPI activates several neutrophil serine proteases, it remains to be determined whether the AAA-promoting effect of DPPI is mediated by neutrophil serine proteases. Approach and Results-Using an elastase-induced AAA model, we demonstrate that the absence of 2 neutrophil serine proteases, neutrophil elastase and proteinase-3, recapitulates the AAA-resistant phenotype of DPPI-deficient mice. DPPI and neutrophil serine proteases direct the in vitro and in vivo release of extracellular structures termed neutrophil extracellular traps (NETs). Administration of DNase1, which dismantles NETs, suppresses elastase-induced AAA in wildtype animals and in DPPI-deficient mice reconstituted with wild-type neutrophils. NETs also contain the cathelicidinrelated antimicrobial peptide that complexes with self-DNA in recruiting plasmacytoid dendritic cells (pDCs), inducing type I interferons (IFNs) and promoting AAA in DPPI-deficient mice. Conversely, depletion of pDCs or blockade of type I IFNs suppresses experimental AAA. Moreover, we find an abundance of human cathelicidin peptide, a 37 amino acid sequence starting with 2 leucines and the human orthologue of cathelicidin-related antimicrobial peptide, in the vicinity of pDCs in human AAA tissues. Increased type I IFN mRNA expression is observed in human AAA tissues and circulating IFN-α is detected in ≈50% of the AAA sera examined. Conclusions-These results suggest that neutrophil protease-mediated NET release contributes to elastase-induced AAA through pDC activation and type I IFN production. These findings increase our understanding of the pathways underlying AAA inflammatory responses and suggest that limiting NET, pDC, and type I IFN activities may suppress aneurysm progression.
A bdominal aortic aneurysm (AAA) is a complex disease associated with male sex, advanced age, hypertension, hypercholesterolemia, coronary artery disease, atherosclerosis, and cigarette smoking. 1 Open surgical repair of large AAA is an effective option in preventing death from rupture; however, it can be associated with high postoperative mortality (≤6%). 2 Endovascular repair carries lower postoperative mortality risk but does not lead to increased long-term survival among older patients. 3 Given the uncertainties that still pertain to endovascular repair, medical treatment to slow progression of AAA represents an attractive alternative.
Although the precise mechanisms that initiate and perpetuate AAA are still under active investigation, studies suggest that they are likely multifactorial, involving an interplay between genetic predisposition, 4 environmental and mechanical stimuli, 5, 6 matrix metalloprotease (MMP)-mediated structural damage, 7 and complex inflammatory process. 8 Whether inflammation is a cause or consequence of aortic wall damage is still being debated. However, a recent prospective study supports a causal role of inflammation in AAA progression. 9 Yet, despite overwhelming evidence of an inflammatory process in AAA, anti-inflammatory therapies aimed at some targets identified in preclinical models have not resulted in consistent AAA stabilization in clinical studies. 10 Therefore, further research is needed to identify and validate additional pathways that participate in the aneurysmal process.
Using an elastase-induced model of AAA, we previously reported that dipeptidyl peptidase I (DPPI) plays a critical role in the development of aneurysm. 11 DPPI is required for the expression of active neutrophil serine proteases (NSPs) neutrophil elastase (NE), cathepsin G (CG), and proteinase 3 (PR3) in mature neutrophils. [12] [13] [14] The absence of DPPI protects mice against elastase-induced AAA due in part to diminished recruitment of neutrophils to the aortic wall. 11 We also established that initiation of the aneurysmal process requires complement activation, releasing anaphylatoxin C5a that attracts neutrophils to the aortic wall. 15, 16 It is generally understood that once recruited to a site of inflammation, neutrophils undergo constitutive apoptosis and are rapidly cleared by phagocytic macrophages. However, there is increasing evidence that during this brief period, neutrophils stimulate a network of immune cell types that together can direct a chronic pathological response. 17 Activated neutrophils form neutrophil extracellular traps (NETs), which were first described as an innate immune response to bacterial infection. 18 NETs are also released in response to noninfectious, endogenous stimuli, such as C5a. 19 We hypothesize that, in elastase-induced AAA, complement activation generates C5a that stimulates neutrophils recruited to the aortic wall to release NETs, propagating the inflammatory responses and culminating in eventual AAA.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

NETs Are Present in Elastase-Perfused Murine Aortic Tissues
A recent report suggests that NETs are present in human AAA tissues and associated with experimental AAA in the context of Porphyromonas gingivalis infection. 20 Although NETs are implicated, whether they are formed in response to endogenous stimuli and their pathogenic mechanisms in AAA are unknown. We used the elastase-induced AAA model to examine whether NETs were associated with aneurysmal development, independent of infection. In this model, a dilute solution of porcine elastase was transiently instilled (for 5 minutes) into the isolated segment of the infrarenal abdominal aorta on day 0, and AAA development was assessed at day 14. 21 NET formation was examined on day 2, during the peak neutrophil recruitment to abdominal aortic wall post elastase perfusion. 11 We observed extensive NET formation in the elastase-perfused wild-type (WT) aorta, as assessed by immunostaining with myeloperoxidase, histone, and DNA ( Figure 1A ). NETs localized mainly to the adventitia, in areas of neutrophil accumulation as previously observed 11 and corroborating the findings in human AAA. 20 Perfusion with heat-inactivated elastase, which did not promote AAA, 21 did not support NET formation in aortic tissues ( Figure 1B) . Concomitant administration of DNase1, which dismantled NETs, 22,23 also largely abrogated NET formation ( Figure 1B ). NETs were mostly absent in DPPI-deficient aorta, confirming our previous report that DPPI is required for neutrophil recruitment in elastaseinduced AAA ( Figure 1B ). 11 Previous studies suggest that NSPs are critical for NET formation in vitro and in vivo. 24 In agreement with these studies, we observed significantly less NET release in the abdominal aortic tissues on day 2, after elastase perfusion of mice deficient in all 3 NSPs (NECGPR3; Figure 1B ).
To corroborate these in vivo findings and further quantify NETs, we purified resting bone marrow neutrophils and stimulated them in vitro with C5a, a complement degradation product that is essential for elastase-induced AAA. 15 C5a stimulated equivalent release of NETs compared with lipopolysaccharide ( Figure 1C and 1D). DPPI-and NECGPR3deficient neutrophils exposed to C5a or lipopolysaccharide for 30 minutes generated significantly less NETs, compared with stimulated WT neutrophils ( Figure 1C and 1D; P<0.001). Despite previous reports describing an essential role for NE in NET release, 24, 25 we observed that NE-deficient neutrophils showed no NETing defect when stimulated with C5a or lipopolysaccharide ( Figure I in the online-only Data Supplement). On the other hand, the combined absence of NE and PR3 resulted in an NET defect similar to that observed with the NECGPR3-deficient neutrophils ( Figure I in the online-only Data Supplement). Finally, we found that WT NETs generated in response to C5a or lipopolysaccharide also contained DNA-associated cathelicidin-related antimicrobial peptide (CRAMP), the murine orthologue of human cathelicidin peptide, a 37 amino acid sequence starting with 2 leucines (LL-37), 26 whereas stimulated DPPI-and NECGPR3-deficient neutrophils released no or minimal amount of CRAMP ( Figure 1E ).
Neutrophil Proteases and NETs Actively Contribute to AAA Development
Having established that DPPI and NSPs are required for optimal NET formation in vivo and in vitro, we next evaluated the contribution of neutrophil proteases and protease-mediated NET release to elastase-induced AAA: after elastase perfusion, there was an immediate dilatation of the abdominal diameter of ≈75%, remaining stable ≤7 days, after which there was a rapid increase in abdominal diameter. 21 AAA was routinely assessed on day 14 and defined as an increase in abdominal diameter of >100% over the preperfused diameter. 11, 15, 21 We observed no significant difference in the immediate postperfusion dilatation between genotypes (Figure 2A ). We confirmed that DPPI deficiency significantly suppressed AAA development (P<0.001 compared with WT; Figure 2A ), corroborating our published results. 11 The overall increase in abdominal diameter of NECGPR3-deficient mice was similarly reduced (P<0.001), confirming the importance of NSPs to aneurysm development ( Figure 2A ). Histological analysis of aortic sections revealed preservation of the elastic lamellae ( Figure 2B ) and reduced inflammatory cell infiltrates, specifically Mac-3 + macrophages, in DPPI-and NECGPR3-deficient mice ( Figure 2C ). To determine which NSPs were required for AAA development, we examined mice with different loss-offunction mutations. Mice deficient in NE developed AAA at WT level, whereas NEPR3-deficient animals developed much smaller AAA (P<0.001; Figure 2D ), suggesting that NE and PR3 are essential for the AAA phenotype.
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To evaluate the role of NETs in AAA, we treated elastase-perfused WT mice with DNase1. DNase1 treatment suppressed AAA development in WT animals (P<0.001 compared with untreated mice), confirming that NETs directly contribute to aneurysm formation ( Figure 2E ). Heat inactivation abolished the effect of DNase1 on AAA ( Figure 2E ). In addition, delaying DNase1 treatment until day 4 post elastase perfusion, after the peak of neutrophil recruitment, 11 resulted in no suppression of AAA, suggesting that neutrophils and extracellular trap components released during the acute response after elastase perfusion were essential for triggering the downstream inflammatory cascade ( Figure II in the online-only Data Supplement). To further confirm that NSPmediated NET release contributed to the aneurysmal process, we adoptively transferred WT neutrophils (10e7) into DPPIdeficient mice after a regimen that has previously been shown to restore susceptibility to AAA in DPPI-deficient mice. 11 Although WT neutrophils promoted aneurysm in DPPIdeficient mice, 11 NECGPR3-deficient neutrophils did not, confirming the importance of NSPs downstream of DPPI in AAA development ( Figure 2E ). Concomitant administration of DNase1 abolished the ability of WT neutrophils to induce AAA in DPPI-deficient mice, whereas inactivated DNase1 had no effect ( Figure 2E ). These results strongly support the concept that NSP-mediated NETs contribute to AAA genesis.
DNA-CRAMP Complexes Contribute to Elastase-Induced AAA
Several NET components have been shown to mediate tissue injuries and stimulate autoimmune responses. 27 Studies suggest that CRAMP, the mouse homologue of human LL-37, facilitates immune recognition of self-DNA by promoting access to and activation of plasmacytoid dendritic cells (pDCs), inducing type I interferons (IFNs) that in turn stimulate T-cell activation. 28, 29 Indeed, we detected an abundance of extracellular CRAMP in day 2 elastase-perfused WT aortas, whereas DPPI-deficient aortas were devoid of NETs and CRAMP ( Figure 3A ). To further evaluate the role of DNA-CRAMP complexes in AAA development, we treated DPPIdeficient mice with exogenous DNA-CRAMP complexes. The administration of exogenous DNA-CRAMP complexes promoted aneurysm development in DPPI-deficient mice, whereas neither CRAMP nor DNA administered individually was effective ( Figure 3B ). Moreover, administration of DNA-scrambled CRAMP to DPPI-deficient mice had no effect on aneurysm size, suggesting a specific role for CRAMP and arguing against the fact that administration of exogenous DNA-CRAMP complexes initiates AAA development through a secondary inflammatory response ( Figure 3B ).
pDCs and Type I IFNs Propagate the Inflammatory Responses in AAA
Although the role of DNA-CRAMP complexes in pDC activation may be assumed from previous studies, 28, 29 their pathogenic mechanism in AAA development has yet to be confirmed. To this end, we first established the presence of pDCs in aortic sections from elastase-perfused mice using Siglec-H as a specific marker. We found a temporal increase in Siglec-H + cells in WT but not in DPPI-deficient mice (Figure 3C and 3D) . Multicolor flow cytometry further revealed that Siglec-H + cells in WT aortic tissues expressed B220, CD11c (low), and PDC antigen 1 (PDCA1), confirming that they were indeed pDCs ( Figure IIIA in the onlineonly Data Supplement). In elastase-perfused DPPI-deficient mice, exogenous administration of DNA-CRAMP complexes significantly increased the recruitment of Siglec-H + cells to the abdominal aorta ( Figure 3E ). Moreover, these Siglec-H + and PR3 (NEPR3), but not NE alone, suppressed the aneurysm development. E, DNase1 treatment (days 0-5) also suppressed AAA development in wild-type (WT) mice, whereas heat-inactivated DNase1 (iDNase1) had no effect. Adoptive transfer of NECGPR3-deficient neutrophils (PMN KO , 10e7 on days 0 and 1) failed to fully reconstitute the AAA phenotype in DPPI-deficient mice. Concomitant DNase1 injections (days 0-3) also prevented DPPI-deficient mice from developing aneurysm after adoptive transfer of WT neutrophils (PMN WT , 10e7 on days 0 and 1), whereas iDNase1 had no effect on WT neutrophil reconstitution and AAA development in DPPI-deficient mice. cells expressed IFN-α ( Figure 3F ), supporting the notion that DNA-CRAMP complexes in NETs amplify the recruitment and activation of pDCs in vivo.
The role of pDCs in aneurysm development was further analyzed through depletion. The anti-PDCA1 monoclonal antibody (mAb) that has been shown to specifically deplete pDCs 30 was administered to naive WT mice on days 2 and 1 before elastase perfusion. Flow cytometry of cells obtained from the spleen, lymph nodes, bone marrow, and peripheral white blood cells harvested 24 hours after elastase perfusion confirmed that anti-PDCA1 mAb did not deplete additional major cell types that may upregulate PDCA1 expression on surgical manipulation and elastase perfusion ( Figure IIIB in the online-only Data Supplement). On the other hand, anti-PDCA1 mAb administration led to significant suppression of AAA development (P<0.01 compared with isotype control; Figure 4A ) and pDC recruitment to abdominal aortic tissues (WT elastase-perfused mice, 481 pDCs per aorta; WT elastase perfused+anti-PDCA1, 40 pDCs per aorta; WT elastase perfused+isotype control, 1202 pDCs per aorta; Figure 4B ). pDC depletion also abrogated CD3 + T-cell recruitment to the aorta (Figure 4C and 4D) and significantly lowered MMP (gelatinase) activity detected by in situ zymography ( Figure 4E and 4F) .
As activated pDCs can produce large amount of type I IFNs, 31 we next sought to inhibit their in vivo activity with an IFN-α receptor 1-specific mAb that has been shown to block IFN-α activity. 32 The administration of anti-IFN-α receptor 1 mAb significantly attenuated elastase-induced AAA (P<0.01 compared with no treatment and isotype control) ( Figure 5A ) and reduced but did not completely abrogate T-cell recruitment ( Figure 5B ). We previously showed that activated T cells in elastase-induced AAA elaborated IFN-γ. 33 Consistent with these results, we found that IFN-α receptor 1 blockade largely suppressed IFN-γ production by T cells (Figure 5C and 5D ) and significantly reduced MMP activity ( Figure 5E ). Taken together, these results suggest that type I IFNs released by pDCs stimulate T cells to produce IFN-γ, the activity of which is essential for MMP activity in elastase-induced AAA. 33 
pDCs and Type I IFNs Are Observed in Human AAAs
Although expression of IFN-γ is widely recognized in human AAA, [33] [34] [35] the presence of type I IFNs has not been described. We first examined human AAA tissues for the presence of the NET component LL-37, the human orthologue of CRAMP. 28 We detected abundant expression of LL-37; some of which localized to the vicinity of CD303 + (a marker for human pDCs) cells ( Figure 6A ) and could be seen taken up inside CD303 + cells ( Figure IV in the online-only Data Supplement). Non-AAA aortic tissues were negative for both LL-37 and CD303 staining ( Figure 6A ). To further confirm the identity of pDCs in human AAA tissues, we showed that CD303 + cells also stained positive for CD85g (Ig-like transcript 7; Figure 6B ), a marker specifically expressed on human pDCs. 36 Activated pDCs produce type I IFNs. Indeed, real-time polymerase chain reaction revealed increased incidence of IFNA2 mRNA expression in AAA tissues (47% in AAA tissues versus 11% in non-AAA tissues; P=0.0479; Figure 6C ). More strikingly, we detected circulating low levels of IFN-α in many patients with AAA (6 of 13), whereas no circulating IFN-α was detectable in non-AAA sera ( Figure 6D; P=0.0122) . In contrast, we found low levels of circulating IFN-γ in the same samples but no significant difference between non-AAA and AAA sera ( Figure 6E ) and low correlation (r=0.0899) between IFN-α and IFN-γ levels in the serum of patients with AAA ( Figure 6F ).
Discussion
NETs are implicated in the pathogenesis of several inflammatory diseases, including rheumatoid arthritis, 37 atherosclerosis, 29, 38 systemic lupus erythematosus, 39 antineutrophil cytoplasmic antibody-associated vasculitis, 40 chronic obstructive pulmonary disease, 41 and types 1 and 2 diabetes mellitus, 42 just to name a few. However, their mechanism of action in AAA pathogenesis remains largely unexplored. We establish that NETs require DPPI and active NSPs, whereas DNase1 dismantles NETs in vivo, suppressing elastase-induced AAA development. DNA-CRAMP complexes released by neutrophils during this NETing process amplify pDC recruitment, inducing IFN-α production and promoting AAA in DPPIdeficient mice. Depletion of pDCs or blockade of type I IFN activity suppresses the aneurysmal process. In addition to previously described NET components, 20 LL-37 and pDCs are The number of CD45 + leukocytes (events) was enumerated by flow cytometry. CD45 + cells that expressed mid to low CD11c, B220 and mSiglec-H were identified as pDCs. The absolute number of pDCs was calculated using the following equation: total number of CD45 + events×percent of CD45 + CD11c lo B220 + Siglec-H + pDCs (expressed as a decimal)/3 (animals). pDC depletion largely abrogated CD3 + T-cell recruitment in elastase-perfused aortas on day 14 (C and D) and markedly inhibited matrix metalloprotease (gelatinase) activity, as detected by in situ zymography (E and F). Gelatinase activity was analyzed by ImageJ and presented as percentage of normalized WT activity, which was set at 100% (F). B, D, and F, n=4 to 5 aortas per treatment and 6 to 9 cross sections per aorta. Scale bar, 100 μm. observed in human AAA tissues, as well as increased type I IFN expression. Circulating IFN-α is also detected in some AAA sera but not in non-AAA controls, suggesting that this cytokine may identify a specific subset of patients with AAA.
NSPs are major constituents of neutrophil azurophil granules. In 2004, Brinkman et al 18 reported that NSPs (NE specifically) participate in the generation of NETs. NETs are composed of extracellular DNA, histone, and several granule proteins, including myeloperoxidase, NSPs, and the antimicrobial peptide LL-37 that complexes with self-DNA to activate pDCs, 28 inducing the release of type I IFNs-α, which in turn stimulate the immune responses. 43 Our in vitro and in vivo data revealed that the absence of NSPs, which are activated by DPPI, 12, 13 largely abrogated NET formation in vitro and in vivo and suppressed AAA. Although our results confirmed the in vivo contribution of DPPI (and active NSPs) to NET production previously suggested by in vitro studies, 14 we found that NE deficiency alone did not abrogate NETs in response to C5a/lipopolysaccharide in vitro nor suppress AAA development in vivo despite previous reports suggesting a critical role for this protease in NET formation. 24, 25 It is thought that NE translocation to the nucleus, where it partially degrades specific histones and promotes chromatin decondensation, represents an essential step in NET formation. 24, 25 Recent studies, however, suggest that NE is dispensable for NET formation in mice, 44 corroborating our findings. Although the precise role of PR3 is not well defined, it is present in NETs 45 and increased circulating levels of PR3 are closely associated with augmented NET formation in patients with type 1 diabetes mellitus. 46 Although the dominant proteolytic activity in NETs is attributed to NE, cleavage sites corresponding to PR3 and CG are also evident. 47 Along this line, we found that NE-and PR3-combined deficiencies largely abrogated in vivo NET formation and significantly attenuated aneurysm development. These results are consistent with a recent study showing that apolipoprotein E/PR3/NE-deficient mice had smaller atherosclerotic plaques that were devoid of NETs. 38 Taken together, these data infer that, in addition to NE, PR3 participates in NETs and NET-dependent inflammatory responses in AAA. However, the exact mechanism by which PR3 promotes NET formation remains to be determined. We also establish that NECGPR3-deficient neutrophils were inefficient at promoting AAA and DNase1 administration suppressed AAA development in DPPI-deficient mice reconstituted with WT neutrophils, confirming that NSPs and neutrophil proteasemediated NET release are required for the aneurysmal process. Although delayed DNase1 treatment did not confer protection against AAA development in the mouse, these results should be considered in the context of the model wherein the aorta is subjected to a single insult (elastase perfusion on day 0). In contrast, human AAA growth proceeds in a discontinuous, staccato manner, 48 suggesting that repeated episodes of insults over time lead to eventual tissue degeneration and aneurysmal dilation. Indeed, there is evidence of ongoing NET formation in human AAA, 20 even in the late stages of disease (ie, large aneurysms), suggesting that controlling NET formation may limit aneurysm progression clinically.
Several studies have shown that self-DNA-LL-37/CRAMP complexes released by neutrophils during NET formation act as a unique trigger of the immune responses. DNA-LL-37/ CRAMP complexes may drive pDCs to release type I IFNs that initiate the inflammatory cascade in atherosclerosis. 29 DNA-containing NETs may also directly prime macrophages for cytokine release. 38 Our data suggest that during the aneurysmal process, DNA-CRAMP complexes released along with NETs may be taken up by pDCs, triggering their activation, inducing type I IFN production and driving the inflammatory responses. Indeed, administration of exogenous DNA-CRAMP complexes rendered the DPPI-deficient mice more susceptible to AAA. Although we could not exclude the possibility that NETs directly activated macrophages in elastase-induced AAA, the fact that pDC depletion abrogated T-cell recruitment/activation, MMP activity, and aneurysm development strongly suggests that NET-dependent priming of pDCs is required for AAA formation in this model. pDCs secrete large amounts of type I IFNs in response to viruses. 31 In addition, chronic activation of pDCs and increased synthesis of type I IFNs in the absence of viral infection also promote immunity and autoimmunity. 49 We demonstrate herein that blockade of IFN-α activity using an IFN-α receptor 1-blocking antibody also abrogated T-cell recruitment/activation and MMP activity and suppressed AAA, thus validating the contribution of pDCs and revealing a requirement for type I IFNs in this preclinical model. Others and we have previously established a role for IFN-γ in experimental AAA, 33, 34 and systematic review suggests that IFN-γ is upregulated in Figure 6 . Plasmacytoid dendritic cells (pDCs) and type I interferons (IFNs) are detected in individuals with abdominal aortic aneurysm (AAA). A, Non-AAA and AAA tissues (n=3) were examined for LL-37 and CD303 in consecutive sections. LL-37 localized to the vicinity of CD303 + cells (arrowheads). B, CD303 + cells (green) colocalized with CD85g (red), confirming their identity as pDCs. C, Expression of IFNA2 in human aortic tissues was detected by real-time polymerase chain reaction (non-AAA=17; AAA=18). IFN-α (D) and IFN-γ (E) levels in serum were determined by cytokine bead array assay (non-AAA=15; AAA=13). F, There was low correlation between IFN-α and IFNγ levels (r=0.0899). Scale bars, 250 μm (A) and 10 μm (B).
large human AAAs. 35 The role of pDCs and type I IFNs in AAA, however, is unknown. We examined human AAA tissues and found an abundance of the NET component LL-37 localizing in close proximity to CD303 + CD85g + pDCs. We also found that ≈50% of human AAA tissues examined harbored detectable levels of IFNA2 mRNA expression. In addition, circulating IFN-α was detectable only in AAA sera, whereas low but equivalent levels of IFN-γ were found in both non-AAA and AAA sera examined. Whether circulating IFN-α level may be used as a specific biomarker that predicts AAA behavior/progression will require larger prospective studies. Nonetheless, we show that the results are highly significant despite the small sample size (n=13-15), suggesting that type I IFNs merit further investigation as additional players in AAA pathogenesis.
In conclusion, our studies demonstrate that neutrophil protease-mediated NET release in response to an endogenous stimulus (such as C5a) contributes to elastase-induced AAA. We propose that NET-mediated pDC recruitment/activation and production of type I IFNs promote a cell-mediated immune response, perpetuating the inflammatory cascade in aneurysm development. We present evidence that pDCs and type I IFNs are found in human AAA tissues and circulating IFN-α is detected in a subset of patients with AAA. These findings increase our understanding of the pathways underlying the mechanisms of AAA inflammation and provide additional targets that may be antagonized to limit or suppress aneurysm progression.
